Full Schedule

Speaker: Jennifer R. Brown, MD, PhD – Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI); Department of Medicine, Harvard Medical School (HMS)

Co-Chair: Elisa ten Hacken, PhD – Weill Cornell Medicine

Co-Chair: Philip Thompson, MBBS (Hons) – Department of Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre and The Sir Peter MaCallum Department of Clinical Oncology, University of Melbourne

Co-Chair: Elisa ten Hacken, PhD – Weill Cornell Medicine

Co-Chair: Basile Stamatopoulos, PhD – Jules Bordet Institute - Laboratory of Clinical Cell Therapy

Chair: William G. Wierda, MD, PhD – University of Texas MD Anderson Cancer Center

Co-Chair: Fleur S. Peters, PhD – Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam

Co-Chair: Marek Mraz, MD, PhD – CEITEC MU, Brno, Czech Rep.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University

Co-Chair: Kerry A. Rogers, MD – The Ohio State University

Co-Chair: Philip Thompson, MBBS (Hons) – Department of Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre and The Sir Peter MaCallum Department of Clinical Oncology, University of Melbourne

Co-Chair: Elisa ten Hacken, PhD – Weill Cornell Medicine

Co-Chair: Basile Stamatopoulos, PhD – Jules Bordet Institute - Laboratory of Clinical Cell Therapy

Keynote Speaker: Anna Schuh, MD, PhD, FRCP, FRCPath – Oxford Molecular Diagnostic Centre, Department of Oncology, University of Oxford

Co-Chair: Elisa ten Hacken, PhD – Weill Cornell Medicine

Co-Chair: Basile Stamatopoulos, PhD – Jules Bordet Institute - Laboratory of Clinical Cell Therapy

Speaker: Jennifer R. Brown, MD, PhD – Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI); Department of Medicine, Harvard Medical School (HMS)

Co-Chair: Gad Getz, PhD – The Broad Institute of MIT and Harvard

Co-Chair: Christopher Oakes, PhD – The Ohio State University

Co-Chair: Catherine J. Wu, MD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Jennifer Abelin, PhD – The Broad Institute

Co-Chair: Adrian Wiestner, MD, PhD – Laboratory of Lymphoid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health

Co-Chair: Silvia Deaglio, MD, PhD – University of Turin

Co-Chair: John F. Seymour, MBBS, FRACP, PhD – Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne

Co-Chair: Lydia Scarfò, MD – Vita-Salute San Raffaele University

Co-Chair: Matthew S. Davids, MD, MMSc – Dana-Farber Cancer Institute (DFCI)

Co-Chair: Mazyar Shadman, MD, MPH – Fred Hutchinson Cancer Center / University of Washington School of Medicine

Co-Chair: Jennifer A. Woyach, MD – Division of Hematology, Department of Internal Medicine, The Ohio State University

Co-Chair: Marek Mraz, MD, PhD – CEITEC MU, Brno, Czech Rep.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University

Co-Chair: Arnon P. Kater, MD, PhD – Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam

Co-Chair: Danielle M. Brander, MD – Duke University Medical Center

Co-Chair: Inhye E. Ahn, MD – Dana-Farber Cancer Institute

Co-Chair: Lili Wang, MD, PhD – Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia; Toni Stephenson Lymphoma Center, Beckman Research Institute, City of Hope Comprehensive Cancer Center

Co-Chair: Carsten Utoft Niemann, MD, PhD – Department of Hematology, Copenhagen University Hospital Rigshospitalet, Denmark; Hematology Research Group, Danish Cancer Institute Research Center, Denmark; Department of Clinical Medicine, Copenhagen University

Co-Chair: Clare Sun, MD – Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health

Keynote Speaker: Mihaela van der Schaar, PhD – University of Cambridge; The Alan Turing Institute

Speaker: Jennifer R. Brown, MD, PhD – Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI); Department of Medicine, Harvard Medical School (HMS)

Speaker: Carsten Utoft Niemann, MD, PhD – Department of Hematology, Copenhagen University Hospital Rigshospitalet, Denmark; Hematology Research Group, Danish Cancer Institute Research Center, Denmark; Department of Clinical Medicine, Copenhagen University

Co-Chair: Anna Schuh, MD, PhD, FRCP, FRCPath – Oxford Molecular Diagnostic Centre, Department of Oncology, University of Oxford

Co-Chair: Geoffrey M. Cook – The Max Foundation

Co-Chair: Jennifer R. Brown, MD, PhD – Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI); Department of Medicine, Harvard Medical School (HMS)